| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/17/2001 | US6262046 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 07/17/2001 | US6262040 Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) |
| 07/17/2001 | US6261559 Inhalation device |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049715A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049689A2 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 07/12/2001 | WO2001049685A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/12/2001 | WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/12/2001 | WO2001049676A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof |
| 07/12/2001 | WO2001049661A1 5-THIA-φ-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 07/12/2001 | WO2001049660A1 A process for preparing 3-{[3-chloro-4-(methylsulfonyl)-phenyl]methylene}-2,4-pentanedione |
| 07/12/2001 | WO2001049654A2 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | WO2001049651A2 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | WO2001049323A1 Combination therapy for the treatment of inflammatory and respiratory diseases |
| 07/12/2001 | WO2001049319A1 Composition containing bacterial antigens, used for the prophylaxis and the treatment of allergic diseases |
| 07/12/2001 | WO2001049315A1 Combination therapy for the treatment of inflammatory and respiratory diseases |
| 07/12/2001 | WO2001049312A2 O-superfamily conotoxin peptides |
| 07/12/2001 | WO2001049305A2 Process for obtaining thylakoids from plants, pure thylakoids and use thereof |
| 07/12/2001 | WO2001049303A1 Multivalent electron active compositions and methods of making and using same |
| 07/12/2001 | WO2001049302A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 07/12/2001 | WO2001049301A1 Methods of using electron active compounds for managing cancer |
| 07/12/2001 | WO2001049263A1 Inhalation particles |
| 07/12/2001 | WO2001049260A2 Y-ifn liquid-droplet aerosol and method |
| 07/12/2001 | WO2001049163A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | WO2001027096A9 Aminomethyl-(hetero)aryl derivatives and their use as tryptase inhibitors |
| 07/12/2001 | WO2001004151A3 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 07/12/2001 | WO2001003669A3 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 07/12/2001 | WO2000076500A3 Compound for use as a medicament for treatment of disorders involving bronchocontraction |
| 07/12/2001 | WO2000005223A3 Heterocyclic derivatives and their use as integrin inhibitors |
| 07/12/2001 | WO2000000510A3 Growth factor modulators |
| 07/12/2001 | US20010007680 Use of a film coating as taste-masking coating of oral dosage forms |
| 07/12/2001 | US20010007651 Masking and eliminating odors; preservative, counterirritant, solubility enhancer, antiseptic, fungicide, microbiocide, anti-infective, healing agent; smoker's-breath; placebo |
| 07/12/2001 | DE19963868A1 Neue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New substituted piperidines, pharmaceutical compositions containing them and methods for their preparation |
| 07/12/2001 | DE19963179A1 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 07/12/2001 | DE19963174A1 Substituierte Pyrrol-Mannichbasen Substituted pyrrole Mannich bases |
| 07/12/2001 | DE10000312A1 Substituierte Aminomethyl-Phenyl-Cyclohexanderivate Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | DE10000311A1 Aminomethyl-Phonyl-Cyclohexanonderivate Aminomethyl-Phonyl-cyclohexanone derivatives |
| 07/12/2001 | CA2396529A1 O-superfamily conotoxin peptides |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396315A1 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them |
| 07/12/2001 | CA2396310A1 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | CA2396304A1 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395803A1 Y-ifn liquid-droplet aerosol and method |
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/11/2001 | EP1114823A2 Substituted benzylamino nitrogen containing non-aromatic heterocycles |
| 07/11/2001 | EP1114822A2 Indoles and tetrahydroisoquinolines containing alpha-keto oxadiazoles as serine protease inhibitors |
| 07/11/2001 | EP1114183A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 07/11/2001 | EP1114182A1 Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases |
| 07/11/2001 | EP1114160A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114149A1 Rnase p polypeptides |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1114053A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 07/11/2001 | EP1114052A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 07/11/2001 | EP1114051A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114048A1 Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 07/11/2001 | EP1114035A1 Quinazoline derivatives and pharmaceutical applications thereof |
| 07/11/2001 | EP1114029A1 Novel compounds |
| 07/11/2001 | EP1114028A1 Aza-bicycles which modulate the inhibition of cell adhesion |
| 07/11/2001 | EP1113800A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 07/11/2001 | EP0927037B1 Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| 07/11/2001 | EP0823896B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 07/11/2001 | CN1303384A Pyrrolo [1,2-a] pyrazine sPLA2 inhibitor |
| 07/11/2001 | CN1303379A 2-Aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303367A Nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303295A Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 07/11/2001 | CN1303290A sPLA Inhibitor ester |
| 07/11/2001 | CN1303285A Microemulsion preconcentrates containing piperidine substance P antagonist |
| 07/11/2001 | CN1303284A 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6] cyclohepta [1,2-b] pyridine oral compositions |
| 07/11/2001 | CN1303276A Drug delivery system comprising tightly compacted solid medicament stock |
| 07/11/2001 | CN1303272A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to upper respiratory tract and/or ear |
| 07/11/2001 | CN1303271A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to lower respiratory tract |
| 07/11/2001 | CN1303270A 气雾剂组合物 Aerosol composition |
| 07/11/2001 | CN1302663A Substrate tablet containing trimetazidine capable of long time controlled release after oral application |
| 07/11/2001 | CN1302655A Compound buccal lozenge of lectuce tea and its preparing process |
| 07/11/2001 | CN1302605A Controlled releasing oral medicine composition |
| 07/10/2001 | US6258843 4-oxy-3-(aryl)phenyl-arylcarbonyloxy compounds useful as phosphodiesterase inhibitors |
| 07/10/2001 | US6258833 Enzyme inhibitors and antiinflammatory agents |
| 07/10/2001 | US6258817 Substituted pyrazin-2-yl-sulphonamide (-3-pyridyl) compounds and uses thereof |
| 07/10/2001 | US6258815 Specific immunophilin ligands as antiasthmatics and immunosuppressants |
| 07/10/2001 | US6258802 Corticoid therapy |
| 07/10/2001 | US6258800 Prodrugs of benzofuranylethyl carbamate NK1 antagonists |
| 07/10/2001 | US6258790 Antisense modulation of integrin α4 expression |
| 07/10/2001 | US6258584 Drug screening for modulators of collagen formation by measuring enzyme activity in presence and absence of compound; reduced activity indicates enzyme inhibitor; antiarthritic agents; antiscarring agents |
| 07/10/2001 | US6258578 His5 |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/10/2001 | US6258372 Xylitol nose spray |
| 07/10/2001 | US6258341 Drug dispersion for oral inhalation and pulmonary absorption |
| 07/10/2001 | CA2017135C Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides, processes for their preparation and their use in medicaments |
| 07/05/2001 | WO2001048231A2 Method of achieving persistent transgene expression |
| 07/05/2001 | WO2001048208A2 Streptococcus pyogenes virulence genes and proteins and their use |
| 07/05/2001 | WO2001047963A2 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047922A2 Azaindoles |
| 07/05/2001 | WO2001047921A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | WO2001047920A1 Benzazole derivatives and their use as jnk modulators |